PropertyValue
?:abstract
  • Covid-19 is a recently-emerged infectious disease caused by the novel severe acute respiratory syndrome coronavirus SARS-CoV2. SARS-CoV2 differs from previous coronavirus infections (SARS and MERS) due to its high infectivity (reproduction value, R(0), typically 2–4) and pre- or asymptomatic transmission, properties that have contributed to the current global Covid-19 pandemic. Identified risk factors for disease severity and death from SARS-Cov2 infection include older age, male sex, diabetes, obesity and hypertension. The reasons for these associations are still largely obscure. Evidence is also emerging that SARS-CoV2 infection exacerbates the underlying pathophysiology of hyperglycemia in people with diabetes. Here, we discuss potential mechanisms through which diabetes may affect the risk of more severe outcomes in Covid-19 and, additionally, how diabetic emergencies and longer term pathology may be aggravated by infection with the virus. We consider roles for the immune system, the observed phenomenon of microangiopathy in severe Covid-19 infection and the potential for direct viral toxicity on metabolically-relevant tissues including pancreatic beta cells and targets of insulin action.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.3389/fendo.2020.582936
?:journal
  • Front_Endocrinol_(Lausanne)
?:license
  • cc-by
?:pdf_json_files
  • document_parses/pdf_json/4b318129406cf41748fb2038280b693bc2083f94.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7578412.xml.json
?:pmcid
?:pmid
?:pmid
  • 33133024.0
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:sha_id
?:source
  • Medline; PMC
?:title
  • Covid-19 and Diabetes: A Complex Bidirectional Relationship
?:type
?:year
  • 2020-10-08

Metadata

Anon_0  
expand all